There are other ways that GLP-1 medications can impact blood pressure: Reduced sodium intake: People taking GLP-1s may end up eating less salty foods because they eat less overall
And for many people, it does
Wegovy is a brand that manufactures Semaglutide in Pens just like Ozempic but it comes if different dosage formats than Ozempic Wegovy (semaglutide) is available in Mexico in several dose pens such as 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg [4]
Who Should NOT Consider Peptides Based on current evidence, I would advise against peptide use in the following individuals: Anyone with a current or recent cancer diagnosis Anyone with a strong family history of hormone-sensitive cancers (breast, ovarian, uterine, prostate, colorectal) Anyone with genetic mutations predisposing to cancer (BRCA1/2, Lynch syndrome, etc.) Anyone with active autoimmune disease or severe inflammatory conditions Pregnant or breastfeeding women Anyone who has not established foundational health practices Competitive athletes (most peptides are banned substances) Anyone seeking a "quick fix" rather than commitment to comprehensive health optimization If Considering Peptides: A Cautious Approach For patients who have established solid foundations, have no contraindications, understand the limitations of current evidence, and wish to explore peptides as a potential adjunct, here is the approach I might considerwith significant caveats: Lower-Risk Starting Point Topical GHK-Cu: This has the most established safety profile and documented benefits for skin health
